Kwame Owusu-Edusei

The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008

Background Millions of cases of sexually transmitted infections (STIs) occur in the United States each year, resulting in substantial medical costs to the nation. Previous estimates of the total direct cost of STIs are quite dated. We present updated direct medical cost estimates of STIs in the United States. Methods We assembled recent (i.e., 2002–2011) cost estimates to determine the lifetime cost per case of 8 major STIs (chlamydia, gonorrhea, hepatitis B virus, human immunodeficiency virus (HIV), human papillomavirus, genital herpes simplex virus type 2, trichomoniasis and syphilis). The total direct cost for each STI was computed as the product of the number of new or newly diagnosed cases in 2008 and the estimated discounted lifetime cost per case. All costs were adjusted to 2010 US dollars. Results Results indicated that the total lifetime direct medical cost of the 19.7 million cases of STIs that occurred among persons of all ages in 2008 in the United States was

Serologic testing for syphilis in the United States: a cost-effectiveness analysis of two screening algorithms.

15.6 (range,

Cost-effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan Africa.

11.0–

A brief review of the estimated economic burden of sexually transmitted diseases in the United States: inflation-adjusted updates of previously published cost studies.

20.6) billion. Total costs were as follows: chlamydia (

The tale of two serologic tests to screen for syphilis--treponemal and nontreponemal: does the order matter?

516.7 [

Chlamydia Screening and Pelvic Inflammatory Disease: Insights from Exploratory Time–Series Analyses

258.3–

The Association Between Racial Disparity in Income and Reported Sexually Transmitted Infections

775.0] million), gonorrhea (

Disparities in sexually transmitted disease rates across the "eight Americas".

162.1 [

Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.

81.1–

Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China.

243.2] million), hepatitis B virus (